Latest It Services News

Challenger has reported a robust FY25 performance, with normalised net profit after tax rising 9% to $456 million and return on equity exceeding targets. The company’s strategic focus on annuities and digital transformation positions it well for continued growth in FY26.

Monadelphous Group Limited reported a robust 12% revenue increase to $2.27 billion and a 35% rise in net profit, driven by strong demand across resources and energy sectors and a record $2.5 billion in new contracts.

Challenger Limited reported a 9% increase in normalised net profit after tax for FY25, driven by strong Life business cash earnings and resilient Funds Management performance despite net outflows. The company also announced an 11% dividend increase and provided positive FY26 EPS guidance amid ongoing regulatory reforms.

Monadelphous Group Limited reported a robust FY25 with $2.27 billion revenue and $158 million net profit, underpinned by strong contract wins and growth in energy and resources sectors.

Challenger Limited celebrates four decades with a robust 9% rise in net profit and a strategic digital transformation, positioning itself at the forefront of Australia’s retirement income market.

Monadelphous Group Limited has announced a fully franked ordinary dividend of AUD 0.39 per share for the half-year ending June 2025, alongside a Dividend Reinvestment Plan offering shareholders a flexible way to reinvest.

Monadelphous Group Limited has reported a robust 35% increase in net profit for the 2025 financial year, alongside a 7% revenue rise, prompting a notable dividend hike.

Challenger Limited reported a robust 48% increase in net profit after tax for FY2025, alongside a 4.6% rise in revenue and an 11.3% dividend hike, reflecting improved operational performance and financial resilience.

HUB24 Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending June 2025, signaling steady shareholder returns ahead of the payment date in October.

Sims Limited reported a 4.1% increase in sales revenue to A$7.494 billion for FY25, alongside a 48.1% jump in underlying EBITDA to A$430 million. Despite a statutory net loss, the company declared a fully franked final dividend of 13 cents per share, reflecting confidence amid market challenges and portfolio reshaping.

Judo Capital Holdings delivered a robust FY25 with strong loan and deposit growth, improved profitability, and a strategic technology upgrade, setting the stage for ambitious FY26 targets.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.